SNOG SYMPOSIUM 2024 – Multidisciplinary Neuro-Oncology Meeting

460

SKU: 9818 Categories: ,

Description

 

SNOG SYMPOSIUM 2024

Multidisciplinary Neuro-Oncology Meeting

25th – 27th  April

Gothenburg
Sweden

Welcome to,

Scandinavian Society of Neuro-oncology (SNOG) symposium, which will be held at Clarion Hotel Draken, Olof Palmes Plats 2, Gothenburg, Sweden 25th – 27th April, 2024.

The symposium is targeted to clinical experts, clinical researchers, basic scientists and students who work with improving lives for patients with brain tumors.

Scandinavian Society of Neuro-oncology (SNOG) was established in 1980s with the overall aim to increase communication between Scandinavian neuro-oncology experts, including both basic scientists and clinicians. One important aim of SNOG is to facilitate new collaborations and improve those already established. The SNOG meeting is an excellent arena to exchange ideas, and this is the key event organized by the society.

Language: English
Number of Participants: 175
Form of Symposium: Lectures and discussion
Registration Fee: 4.600 SKR
Application deadline: March 1, 2024 – Note! Limited number  of places, first came – first served!

What is included in the registration fee?

Admission to all scientific sessions
Admission to exhibition
Final Program
Coffee/tea during breaks
Lunch April 25, April 26, April 27
Dinner April 26

About hotel reservation
We highly recommend you to reserve a room at Clarion Hotel Draken, where the symposium is also held. They have reserved rooms for the participants with a special price.

More information about the hotel by this link https://www.strawberry.se/hotell/sverige/goteborg/clarion-hotel-draken/

You can reserve your hotel room by clicking the link below:
Clarion Hotel Draken 25-27 april 2024

Special prices for participants:
Room for one person (single room) 155 EUR per night
Room for two persons (double room) 175 EUR per night
All prices are per room and per night, including breakfast buffet, Wi-Fi and VAT.

These prices are valid until February 23, 2024.

NOTE! Hotel rooms are not included in the congress fee.  The hotel rooms have to be booked and paid by each participant.

 

We hope that this will be an interesting and productive meeting and look forward to see you in Gothenburg in April 2024.

Welcome!

Asgeir Jakola
President SNOG
on behalf of
SNOG Organizing committee

Go to the registration form

Skriv ut
April 25    
12.00 - 12.10 Welcome Asgeir Jakola, Gothenburg/Sweden
  Cognition - Chair - Anneli Ozanne  
12.10 - 12.40 Cognitive rehabilitation - lessons learned Karin Gehring, Tillburg/The Netherlands
12.40 - 12.47 Abstracts  
12.50 - 13.05 Cognitive trajectories in IDH mut glioma Isabelle Rydén, Gothenburg/Sweden
  Brain tumor diagnosis; beyond clinical routine - Chair - Bjarne W. Kristensen  
13.10 - 13.40 Liquid biopsies Susan Short, Leeds/UK
13.40 - 14.00 Brain Cancer: From Biology to Early Detection Petra Hamerlik, Manchester/UK
14.00 - 14.15 DNA methylation analysis of liquid biopsies in brain tumors Kirsi Rautajoki, Finland
14.15 - 14.30 PET in diagnosis of brain tumors Ian Law, Copenhagen/DK
14.30 - 14.37 Abstract  
14.40 - 14.55 Metabolic patterns before glioma diagnosis Sebastian Löding, Umeå/Sweden
14.55 - 15.15 Coffee/Exhibition  
  Radiotherapy - Chair - Maria Sandström  
15.15 - 15.30 Novel PET tracers in mangement of brain metastasis Pirjo Laakkonen, Helsinki/Finland
15.30 - 15.45 Swedish proton experience in LGG / PRO GLIO UPDATE Malin Blomstrand, Gothenburg/Sweden
15.45 - 15.52 Abstracts  
15.55 - 16.25 Experience of intraoperative radiotherapy Klaus Henning Kahl, Augsburg/Germany
  Tumor microenvironment - Chair - Kirsi Rautajoki  
16.30 - 17.00 Tumor-host interdependance Vidhya Madapusi Ravi, Freiburg/Germany
17.00 - 17.15 Tertiary lymphoid structures; relevance in brain tumors? Anna Dimberg, Uppsala/Sweden
17.15 - 17.30 Tumor surfaceome - the key to effective immunotherapy? Mattias Belting, Lund/Sweden
17.30 - 17.45 Influence of the microenvironment on chemosensitivity in glioblastoma Rikke Frydendahl Sick Olsen, Odense/Denmark
17.45 - 18.00 Coffee/Exhibition  
  New concepts in IDH mutant gliomas  
18.00 - 18.30 Vorasidenib in IDH mutated gliomas Roberta Ruda, Turin/Italy
     
April 26
   
  Meningiomas - Chair - Anneli Ozanne  
08.30 - 08.45 Epidemiology and Incidental meningiomas Olivia Näslund, Gothenburg/Sweden
08.45 - 09.15 Molecular classification of meningiomas Felix Sahm, Heidelberg/Germany
09.15 - 09.30 Radiotherapy as primary option for meningiomas Bente Sandvei Skeie, Bergen/Norway
09.30 - 09.45 Copenhagen meningioma score Tiit Mathiesen, Copenhagen/Denmark
09.45 - 09.52 Abstract  
09.52 - 09.59 Abstract  
10.00 - 10.07 Abstract  
10.07 - 10.14 Abstract  
10.15 - 10.45 Meningiomas, new horizons Thomas Graillon, Marseille/France 
11.00 - 12.00 Poster viewing - Guided  
12.00 - 13.00  Lunch  
  Innovative study designs - Chair - Jiri Bartek  
13.00 - 13.20 Register randomized trials - what can neuro-oncology learn from the BROKEN-SWEDEHEART? Elmir Omerovic, Gothenburg/Sweden
13.20 - 13.40 Window-of-opprtunity studies Michael Vogelbaum, Tampa/USA
13.40 - 14.00 Basket and umbrella trials Ulrik Lassen, Copenhagen/Denmark
  Basic research topic - Chair - Helena Carén  
14.15 - 14.30 Spatial organization of diffuse gliomas Aliisa Tiihonen, Finland
14.30 - 14.45 GBM organoids, how and why Magnar Bjørås, Trondheim/Norway
14.45 - 15.00 3D chromatin organization of the glioblastoma genome Silvia Remeseiro, Umeå/Sweden
15.00 - 15.15 Novel insight into glioblastoma heterogeneity Bjarne W. Kristensen, Copenhagen/Denmark
15.15 - 15.22 Abstract  
15.22 - 15.29 Abstract  
15.30 - 16.00 Coffee/Exhibition  
  Novel therapies  
16.00 - 16.30 Immunotherapies including CAR-T in neuro-oncology Magnus Essand, Uppsala/Sweden
16.30 - 17.00 Neurosurgical role in oncological therapy: towards truly multidisciplinary treatment? Michael Vogelbaum, Tampa/USA
     
19.00 - 22.00 CONGRESS DINNER  
     
April 27    
  ABSTRACT SESSION and quality of life - Chair - Anja Smits  
09.00 - 09.10 Best abstract clincal  
09.10 - 09.20 Best abstract clincal  
09.20 - 09.35 Reproductive health and sexuality Claudia Lampic, Umeå/Sweden
09.35 - 09.50 Feasibility of shared decision making in neuro-oncology Helle Sørensen Von Essen, Odense/Denmark
09.50 - 10.00 Functional consequences of SMA and M1 resections Mattias Stålnacke, Umeå/Sweden
10.00 - 10.10 Support to patients with glioblastoma and their proxies Pernilla Ståhl, Gothenburg/Sweden
10.10 - 10.30 Coffee/Exhibition  
  Glioma origin and growth - Chair - Magnus Olivecrona  
10.30 - 10.37 Best abstract basic  
10.37 - 10.45 Best abstract basic  
10.45 - 11.00 Are gliomas inheritable? Adam Rosenbaum, Umeå/Sweden
11.00 - 11.15 Glioma invasion: what can we learn from current models? Sven Nelander, Uppsala/Sweden
  Trial updates with focus on the Nordics - Chair -Roger Henriksson  
11.20 - 11.27 Abstract  
11.28 - 11.35 Abstract  
11.35 - 11.50 Temozolamide and Lomustine in MGMT methylated glioblastoma Annika Malmström, Linköping/Sweden
11.50 - 12.45  Lunch  
  Trial updates with focus on the Nordics continues…  
12.45 - 13.00 Optimized PCNSL treatment with BBB disruption Hanne Kuitunen, Oulo/Finland
13.00 - 13.15 Scandinavian standard of care in surgical management of LGG Margret Jensdottir, Stockholm/Sweden
13.15 - 13.30 Skull remodelling to improve TTF Anders Korshøj, Aarhus/Denmark
13.30 - 13.45 Norwegian Brain Tumor Consortium: improved access to trials Petter Brandal, Oslo/Norway
13.45 - 14.00  Tumor deliniation, novel fluorescent agents Jane S. Rasmussen, Copenhagen/Denmark
14.00 - 14.10 ADJOURN Asgeir Jakola, Gothenburg/Sweden

Go to the registration form

Skriv ut